Cargando…
Comparative clinical utility of once-weekly subcutaneous abatacept in the management of rheumatoid arthritis
Biologic therapies in rheumatoid arthritis are now part of standard practice for disease that proves difficult to control with conventional disease-modifying anti-rheumatic drugs. While anti-tumor necrosis factor therapies have been commonly used, other targeted biologic therapies with different mec...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011896/ https://www.ncbi.nlm.nih.gov/pubmed/24812514 http://dx.doi.org/10.2147/TCRM.S60740 |